313 related articles for article (PubMed ID: 17239967)
1. Antiviral treatment of Coxsackie B virus infection in human pancreatic islets.
Berg AK; Olsson A; Korsgren O; Frisk G
Antiviral Res; 2007 Apr; 74(1):65-71. PubMed ID: 17239967
[TBL] [Abstract][Full Text] [Related]
2. Antiviral effect of nicotinamide on enterovirus-infected human islets in vitro: effect on virus replication and chemokine secretion.
Moëll A; Skog O; Ahlin E; Korsgren O; Frisk G
J Med Virol; 2009 Jun; 81(6):1082-7. PubMed ID: 19382275
[TBL] [Abstract][Full Text] [Related]
3. Complete nucleotide sequence of a Coxsackievirus B-4 strain capable of establishing persistent infection in human pancreatic islet cells: effects on insulin release, proinsulin synthesis, and cell morphology.
Yin H; Berg AK; Westman J; Hellerström C; Frisk G
J Med Virol; 2002 Dec; 68(4):544-57. PubMed ID: 12376963
[TBL] [Abstract][Full Text] [Related]
4. Effects on isolated human pancreatic islet cells after infection with strains of enterovirus isolated at clinical presentation of type 1 diabetes.
Elshebani A; Olsson A; Westman J; Tuvemo T; Korsgren O; Frisk G
Virus Res; 2007 Mar; 124(1-2):193-203. PubMed ID: 17169456
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory gene expression in Coxsackievirus B-4-infected human islets of Langerhans.
Olsson A; Johansson U; Korsgren O; Frisk G
Biochem Biophys Res Commun; 2005 May; 330(2):571-6. PubMed ID: 15796921
[TBL] [Abstract][Full Text] [Related]
6. Enterovirus infections with beta-cell tropic strains are frequent in siblings of children diagnosed with type 1 diabetes children and in association with elevated levels of GAD65 antibodies.
Frisk G; Tuvemo T
J Med Virol; 2004 Jul; 73(3):450-9. PubMed ID: 15170642
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P
J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864
[TBL] [Abstract][Full Text] [Related]
8. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S
Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817
[TBL] [Abstract][Full Text] [Related]
9. Tissue culture of isolated human pancreatic islets infected with different strains of coxsackievirus B4: assessment of virus replication and effects on islet morphology and insulin release.
Frisk G; Diderholm H
Int J Exp Diabetes Res; 2000; 1(3):165-75. PubMed ID: 11467407
[TBL] [Abstract][Full Text] [Related]
10. Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells.
Horwitz MS; Ilic A; Fine C; Balasa B; Sarvetnick N
Clin Immunol; 2004 Feb; 110(2):134-44. PubMed ID: 15003810
[TBL] [Abstract][Full Text] [Related]
11. Infection of human islets of Langerhans with two strains of Coxsackie B virus serotype 1: assessment of virus replication, degree of cell death and induction of genes involved in the innate immunity pathway.
Anagandula M; Richardson SJ; Oberste MS; Sioofy-Khojine AB; Hyöty H; Morgan NG; Korsgren O; Frisk G
J Med Virol; 2014 Aug; 86(8):1402-11. PubMed ID: 24249667
[TBL] [Abstract][Full Text] [Related]
12. Interferons induce an antiviral state in human pancreatic islet cells.
Hultcrantz M; Hühn MH; Wolf M; Olsson A; Jacobson S; Williams BR; Korsgren O; Flodström-Tullberg M
Virology; 2007 Oct; 367(1):92-101. PubMed ID: 17559902
[TBL] [Abstract][Full Text] [Related]
13. In vitro infection of mouse pancreatic islet cells with coxsackie viruses.
Bopegamage SA; Petrovicová A
Acta Virol; 1994 Oct; 38(5):251-5. PubMed ID: 7725998
[TBL] [Abstract][Full Text] [Related]
14. Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants.
Groarke JM; Pevear DC
J Infect Dis; 1999 Jun; 179(6):1538-41. PubMed ID: 10228078
[TBL] [Abstract][Full Text] [Related]
15. Severe Coxsackie virus B infection in preterm newborns treated with pleconaril.
Bauer S; Gottesman G; Sirota L; Litmanovitz I; Ashkenazi S; Levi I
Eur J Pediatr; 2002 Sep; 161(9):491-3. PubMed ID: 12200608
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of coxsackievirus-induced damage to human pancreatic beta-cells.
Roivainen M; Rasilainen S; Ylipaasto P; Nissinen R; Ustinov J; Bouwens L; Eizirik DL; Hovi T; Otonkoski T
J Clin Endocrinol Metab; 2000 Jan; 85(1):432-40. PubMed ID: 10634421
[TBL] [Abstract][Full Text] [Related]
17. Strains of coxsackie virus B4 differed in their ability to induce acute pancreatitis and the responses were negatively correlated to glucose tolerance.
Hindersson M; Orn A; Harris RA; Frisk G
Arch Virol; 2004 Oct; 149(10):1985-2000. PubMed ID: 15669109
[TBL] [Abstract][Full Text] [Related]
18. Prevalent human coxsackie B-5 virus infects porcine islet cells primarily using the coxsackie-adenovirus receptor.
Myers SE; Brewer L; Shaw DP; Greene WH; Love BC; Hering B; Spiller OB; Njenga MK
Xenotransplantation; 2004 Nov; 11(6):536-46. PubMed ID: 15479464
[TBL] [Abstract][Full Text] [Related]
19. New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3.
Schmidtke M; Wutzler P; Zieger R; Riabova OB; Makarov VA
Antiviral Res; 2009 Jan; 81(1):56-63. PubMed ID: 18840470
[TBL] [Abstract][Full Text] [Related]
20. Anti-enteroviral triple combination of viral replication inhibitors: activity against coxsackievirus B1 neuroinfection in mice.
Stoyanova A; Nikolova I; Pürstinger G; Dobrikov G; Dimitrov V; Philipov S; Galabov AS
Antivir Chem Chemother; 2015 Dec; 24(5-6):136-147. PubMed ID: 27815331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
